CD36 and myelodysplastic syndrome: In addition, the sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of CD36 RMFI to differentiate MDS and MA were 94.3%, 67.6%, 80.6%, 73.3% and 92.6%, respectively.